Moede, Tilo
Leibiger, Barbara
Vaca Sanchez, Pilar
Daré, Elisabetta
Köhler, Martin
Muhandiramlage, Thusitha P.
Leibiger, Ingo B.
Berggren, Per-Olof
Funding for this research was provided by:
Karolinska Institutet
Vetenskapsrådet
Familjen Erling-Perssons Stiftelse
Novo Nordisk Fonden
Stichting af Jochnick Foundation
Diabetesförbundet
Scandia Insurance Company Limited
Diabetes Research and Wellness Foundation
Berth von Kantzow’s Foundation
Strategic Research Program in Diabetes at Karolinska Institutet
European Research Council (ERC-2018-AdG 834860 EYELETS)
Swedish Foundation for Strategic Research
Knut och Alice Wallenbergs Stiftelse
Karolinska Institute
Article History
Received: 31 July 2020
Accepted: 2 November 2020
First Online: 19 November 2020
Competing interests
: P-OB is cofounder and CEO of the biotech company Biocrine AB. BL, IBL and MK are consultants for the same company. TM, PVS, ED and TPM have no relationships or activities that might bias, or be perceived to bias, this work.